What You Should Know:
- According to a new report from Allison + Partners, 57% of respondents said it will be possible to achieve “Health 4.0” in the next 3-5 years
- The report illustrates that the biggest hurdles include legislative and regulatory policy, lack of tech talent, and little understanding of health technologies and that the opportunities outweigh the challenges
Health 4.0: Barriers and Solutions
During the pandemic, there was a record-breaking infusion of capital into
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
AmerisourceBergen Launches EHR-Integrated Digital Therapeutics Platform
What You Should Know:
This week, AmerisourceBergen announced plans to launch DTx Connect, a fully integrated ordering, dispensing and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and diagnostics.
- Several developers plan to pilot DTx Connect, which aims to reduce barriers that physicians and patients face across the ordering and fulfillment of digital therapeutics and diagnostics.
Digital Therapeutics Market
Read More
Elevation Oncology Secures $50M Loan Facility with K2 HealthVentures
What You Should Know:
Elevation Oncology, a clinical-stage biopharmaceutical company focused on the development of precision oncology products for patients with genomically defined cancers, today announced that it has secured a $50M senior secured loan facility from funds managed by K2 HealthVentures.
Elevation plans to use the funding from the facility will primarily support the exclusive license of EO-3021 (SYSA1801) outside of Greater China from CSPC Pharmaceutical Group and the
Read More
Caption Health, Heartbeat Health Partner to Provide Access to Cardiac Care
What You Should Know:
- Caption Health and Heartbeat Health today announced a partnership that will enable providers to offer their patients earlier access to cardiovascular care than ever before possible.
- Together, the partners are increasing access to early cardiac evaluations and care by providing these two innovations as a value-based bundle for health providers, payers, and value-based care organizations.
Improving Access To Cardiac Care
Limited access to cardiac diagnosis and
Read More
Linus Health Launches AI Platform to Detect, Delay Dementia
What You Should Know:
- Linus Health launches the first iPad-based cognitive screening platform able to detect cognitive decline such as dementia years before the human eye could ever do so.
- Linus is now offering a solution to empower PCPs to not only pinpoint cognitive issues in just minutes but also leverage AI to provide patients with evidence-based early interventions
IPad-Based Brain Health Platform
Projections estimate that the number of people in the US with Alzheimer's
Read More
The Mounting Provider Burden of Patients Disconnected from Their Cardiac Implantable Electronic Devices (CIEDs)
The first implantation of a pacemaker in a human occurred in 1958. Since then, the technology behind permanent cardiac rhythm management has steadily evolved, enabling a variety of implants known collectively as cardiac implantable electronic devices (CIEDs). Today, CIEDs are the standard of care for a range of cardiac arrhythmias, and researchers estimate that 1.2–1.4 million of these devices are implanted annually worldwide. And experts predict that number will continue to increase in years to
Read More
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers
What You Should Know:
- NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS).
- This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More
Syapse Raises $35M to Expand Learning Health Network
What You Should Know:
- Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers.
- The investment will allow Syapse to expand its artificial intelligence and machine learning capabilities, making it more efficient to uncover meaningful insights from real-world oncology data.
Syapse, a San Francisco, CA-based real-world evidence company accelerating the
Read More
UCLA Research Uses Saliva to Detect Cancer Biomarkers
What You Should Know:
- Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry that successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva.
- Specifically, amplified EGFR mutations associated with non-small cell lung cancer (NSCLC) using Spectrum’s saliva collection and preservation system with the Electric
Read More
